Back to results
US 7,732,213 B2Granted
Method of evaluating patient hemostasis
AssigneeCoramed Healthcare, Inc.
InventorsEli Cohen, Roslyn Cohen
Life of this patent
Estimating the term…
Abstract
A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of a patient hemostasis condition.
Claims24
A method of evaluating patient hemostasis, the method comprising:
- testing a first portion of a blood sample obtained from a patient to determine a first quantitative indication of a first blood sample hemostasis characteristic, the first portion first being prepared so that during testing of the first portion the first blood sample hemostasis characteristic is distinguishable from other blood sample hemostasis characteristics;
- testing a second portion of the blood sample obtained from the patient to determine a second quantitative indication of a second blood sample hemostasis characteristic, the second portion first being prepared so that during testing of the second portion the second blood sample hemostasis characteristic is distinguishable from other blood sample hemostasis characteristics;
- calculating a third blood sample hemostasis characteristic using the first blood sample hemostasis characteristic and the second blood sample hemostasis characteristic;
- and
- evaluating a hemostasis condition of the patient from which the blood sample was taken at least based upon the third blood sample hemostasis characteristic.
2 more elements
Dependencies are inferred from the claim text.